VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by eyeNteeon Nov 17, 2013 10:08pm

156 Views

Post# 21914482

RE:Tomorrows Open?

Yes artiste an announcement on sales numbers would be very timely after the thrashing we took from the fda denial..we all knew a fda regection would have a brutal initial reaction but this company is far from done..an approval would have expidited our progress but we have an excelent product that is being marketed elsewhere and they are not giving up on fda approval.

Bullboard Posts

Calibre discovers significant gold in Newfoundland